AbbVie Inc (NYSE: ABBV) Q4 2019 Earnings Call Transcript
AbbVie Inc (NYSE: ABBV) Q4 2019 Earnings Conference Call February 07, 2020 Corporate Participants: Liz Shea — Vice President of Investor Relations Richard A. Gonzalez — Chairman of the Board…
AlphaGraphs
Fresh hope for Covid-19 patients as AbbVie (ABBV) leads studies on HIV drug
For some of the leading drugmakers, currently, the first priority is to find an effective treatment for Covid-19, which was declared a pandemic by the…
Market News
AbbVie (ABBV) Q4 earnings preview: Generic competition might weigh on results
With only a few weeks left for closing the high-value acquisition of Allergan, AbbVie (NYSE: ABBV) is busy doing the groundwork for the integration. The…
Market News
AbbVie (NYSE: ABBV) Q3 profit dips 31% but beats estimates
AbbVie Inc. (NYSE: ABBV) reported a 31% dip in earnings for the third quarter of 2019 due to higher costs and expenses. However, the results…